Changes in Body Mass Index and Atherosclerotic Disease Risk Score After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide

BACKGROUND: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF)-containing antiretroviral therapy (ART) can improve renal function and bone mineral density in people with human immunodeficiency virus (PWH). The switch can also negatively influence cholesterol, but chang...

Descripción completa

Detalles Bibliográficos
Autores principales: Schafer, Jason J, Sassa, Kaitlin N, O’Connor, Jaclyn R, Shimada, Ayako, Keith, Scott W, DeSimone, Joseph A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786703/
https://www.ncbi.nlm.nih.gov/pubmed/31660372
http://dx.doi.org/10.1093/ofid/ofz414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6786703/
https://www.ncbi.nlm.nih.gov/pubmed/31660372
http://dx.doi.org/10.1093/ofid/ofz414

Ejemplares similares